Expired carbon monoxide levels in self-reported smokers and nonsmokers in prison.

PubWeight™: 1.47‹?› | Rank: Top 5%

🔗 View Article (PMID 17008192)

Published in Nicotine Tob Res on October 01, 2006

Authors

Karen L Cropsey1, Gloria D Eldridge, Michael F Weaver, Gabriela C Villalobos, Maxine L Stitzer

Author Affiliations

1: Douglas Wilder School of Government and Public Affairs, Virginia Commonwealth University, Richmond, VA 23284, USA. klcropsey@hsc.vcu.edu

Associated clinical trials:

The Effectiveness of Smoking Cessation Clinics Combined With Coach-assisted Lifestyle Change in Prediabetic Smokers | NCT01926041

Articles citing this

Prison tobacco control policies and deaths from smoking in United States prisons: population based retrospective analysis. BMJ (2014) 1.53

A test of motivational plus nicotine replacement interventions for HIV positive smokers. AIDS Behav (2007) 1.37

Smoking cessation intervention for female prisoners: addressing an urgent public health need. Am J Public Health (2008) 1.35

Differential success rates in racial groups: results of a clinical trial of smoking cessation among female prisoners. Nicotine Tob Res (2009) 1.30

Optimal carbon monoxide criteria to confirm 24-hr smoking abstinence. Nicotine Tob Res (2012) 1.16

Breath carbon monoxide and semiquantitative saliva cotinine as biomarkers for smoking. Hum Psychopharmacol (2010) 1.11

Using breath carbon monoxide to validate self-reported tobacco smoking in remote Australian Indigenous communities. Popul Health Metr (2010) 1.01

Relative performance of common biochemical indicators in detecting cigarette smoking. Addiction (2011) 0.99

Assessing smoking status in disadvantaged populations: is computer administered self report an accurate and acceptable measure? BMC Med Res Methodol (2011) 0.98

How low should you go? Determining the optimal cutoff for exhaled carbon monoxide to confirm smoking abstinence when using cotinine as reference. Nicotine Tob Res (2014) 0.92

A tutorial on principal stratification-based sensitivity analysis: application to smoking cessation studies. Clin Trials (2010) 0.91

A mobile-phone-based breath carbon monoxide meter to detect cigarette smoking. Nicotine Tob Res (2014) 0.90

Measuring tobacco use in a prison population. Nicotine Tob Res (2010) 0.89

Impact of self-initiated pre-quit smoking reduction on cessation rates: results of a clinical trial of smoking cessation among female prisoners. Addict Behav (2010) 0.86

Design considerations for a study to evaluate the impact of smoking cessation treatment on stimulant use outcomes in stimulant-dependent individuals. Contemp Clin Trials (2011) 0.85

The impact of quitting smoking on weight among women prisoners participating in a smoking cessation intervention. Am J Public Health (2010) 0.83

Contingency management for behavior change: applications to promote brief smoking cessation among opioid-maintained patients. Exp Clin Psychopharmacol (2011) 0.82

Queer quit: a pilot study of a smoking cessation programme tailored to gay men. BMC Public Health (2014) 0.79

A tale of two stimulants: mentholated cigarettes may play a role in cocaine, but not methamphetamine, dependence. Drug Alcohol Depend (2013) 0.78

Smoking and other drug characteristics of aboriginal and non-aboriginal prisoners in australia. J Addict (2013) 0.77

Race and Medication Adherence Moderate Cessation Outcomes in Criminal Justice Smokers. Am J Prev Med (2015) 0.76

Agreement between exhaled breath carbon monoxide threshold levels and self-reported cigarette smoking in a sample of male adolescents in Jordan. Int J Environ Res Public Health (2015) 0.76

COMT polymorphism modulates the resting-state EEG alpha oscillatory response to acute nicotine in male non-smokers. Genes Brain Behav (2015) 0.75

Heroin use impairs smoking cessation among Australian prisoners. BMC Public Health (2013) 0.75

Physical Activity and Quit Motivation Moderators of Adolescent Smoking Reduction. Am J Health Behav (2017) 0.75

Articles by these authors

Effect of prize-based incentives on outcomes in stimulant abusers in outpatient psychosocial treatment programs: a national drug abuse treatment clinical trials network study. Arch Gen Psychiatry (2005) 6.97

A clinical laboratory model for evaluating the acute effects of electronic "cigarettes": nicotine delivery profile and cardiovascular and subjective effects. Cancer Epidemiol Biomarkers Prev (2010) 5.44

Effects of lower-cost incentives on stimulant abstinence in methadone maintenance treatment: a National Drug Abuse Treatment Clinical Trials Network study. Arch Gen Psychiatry (2006) 4.64

Randomized Trial of Reduced-Nicotine Standards for Cigarettes. N Engl J Med (2015) 3.63

Smoking in the absence of nicotine: behavioral, subjective and physiological effects over 11 days. Addiction (2007) 2.84

Smoking among female prisoners: an ignored public health epidemic. Addict Behav (2004) 2.57

The influence of transdermal nicotine on tobacco/nicotine abstinence and the effects of a concurrently administered cigarette in women and men. Exp Clin Psychopharmacol (2008) 2.44

Waterpipe tobacco smoking and cigarette smoking: a direct comparison of toxicant exposure and subjective effects. Nicotine Tob Res (2010) 2.26

Predictors of risky sex of young men after release from prison. Int J STD AIDS (2003) 2.11

Contingency management for the treatment of methamphetamine use disorders. Am J Psychiatry (2006) 1.99

A reinforcement-based therapeutic workplace for the treatment of drug abuse: three-year abstinence outcomes. Exp Clin Psychopharmacol (2002) 1.81

A randomized trial of long-term reinforcement of cocaine abstinence in methadone-maintained patients who inject drugs. J Consult Clin Psychol (2004) 1.76

The association of self-reported neighborhood disorganization and social capital with adolescent alcohol and drug use, dependence, and access to treatment. Drug Alcohol Depend (2007) 1.75

Abuse liability assessment of tobacco products including potential reduced exposure products. Cancer Epidemiol Biomarkers Prev (2009) 1.74

Prize-based contingency management does not increase gambling. Drug Alcohol Depend (2006) 1.63

Clinical laboratory assessment of the abuse liability of an electronic cigarette. Addiction (2012) 1.62

Transdermal nicotine-induced tobacco abstinence symptom suppression: nicotine dose and smokers' gender. Exp Clin Psychopharmacol (2006) 1.59

Cognitive impairment in methadone maintenance patients. Drug Alcohol Depend (2002) 1.56

Pharmacotherapy for nicotine dependence. CA Cancer J Clin (2005) 1.54

Design and methodological considerations of an effectiveness trial of a computer-assisted intervention: an example from the NIDA Clinical Trials Network. Contemp Clin Trials (2011) 1.38

Nicotine delivery, cardiovascular profile, and subjective effects of an oral tobacco product for smokers. Nicotine Tob Res (2008) 1.36

Acute effects of waterpipe tobacco smoking: a double-blind, placebo-control study. Drug Alcohol Depend (2011) 1.34

Experimental evidence for a causal relationship between smoking lapse and relapse. J Abnorm Psychol (2006) 1.30

Differential success rates in racial groups: results of a clinical trial of smoking cessation among female prisoners. Nicotine Tob Res (2009) 1.30

Delay of smoking gratification as a laboratory model of relapse: effects of incentives for not smoking, and relationship with measures of executive function. Behav Pharmacol (2009) 1.29

An item response theory modeling of alcohol and marijuana dependences: a National Drug Abuse Treatment Clinical Trials Network study. J Stud Alcohol Drugs (2009) 1.27

Methadone doses of 100 mg or greater are more effective than lower doses at suppressing heroin self-administration in opioid-dependent volunteers. Addiction (2005) 1.25

Effects of a randomized contingency management intervention on opiate abstinence and retention in methadone maintenance treatment in China. Addiction (2011) 1.22

Management of chronic nonmalignant pain: a needs assessment in an internal medicine resident continuity clinic. J Opioid Manag (2008) 1.22

Utilization of communication technology by patients enrolled in substance abuse treatment. Drug Alcohol Depend (2012) 1.22

Reinforcement-based therapy: 12-month evaluation of an outpatient drug-free treatment for heroin abusers. Drug Alcohol Depend (2005) 1.21

Effects of cigarette nicotine content and smoking pace on subsequent craving and smoking. Psychopharmacology (Berl) (2002) 1.19

Opioid abuse and cognitive performance. Drug Alcohol Depend (2004) 1.17

Clinical characteristics of treatment-seeking adolescents with opioid versus cannabis/alcohol use disorders. Drug Alcohol Depend (2008) 1.16

The dose effects of short-term dronabinol (oral THC) maintenance in daily cannabis users. Drug Alcohol Depend (2012) 1.14

The construct and measurement equivalence of cocaine and opioid dependences: a National Drug Abuse Treatment Clinical Trials Network (CTN) study. Drug Alcohol Depend (2009) 1.13

Identifying pregnant women at risk for early attrition from substance abuse treatment. J Subst Abuse Treat (2004) 1.10

High-dose methadone produces superior opioid blockade and comparable withdrawal suppression to lower doses in opioid-dependent humans. Psychopharmacology (Berl) (2002) 1.09

Use of a low-cost incentive intervention to improve counseling attendance among methadone-maintained patients. J Subst Abuse Treat (2005) 1.07

Alcohol-use disorders in the critically ill patient. Chest (2010) 1.07

Pharmacotherapy treatment in substance-dependent correctional populations: a review. Subst Use Misuse (2005) 1.06

Effects of varenicline on abstinence and smoking reward following a programmed lapse. Nicotine Tob Res (2012) 1.05

Correlates of stimulant treatment outcome across treatment modalities. Am J Drug Alcohol Abuse (2009) 1.05

Predictors of abstinence: National Institute of Drug Abuse multisite buprenorphine/naloxone treatment trial in opioid-dependent youth. J Am Acad Child Adolesc Psychiatry (2011) 1.05

Subjective effects of the nicotine lozenge: assessment of abuse liability. Psychopharmacology (Berl) (2003) 1.04

The added risk of opioid problem use among treatment-seeking youth with marijuana and/or alcohol problem use. Addiction (2010) 1.03

Addiction and pain. Am J Addict (2003) 1.03

Heterogeneity of stimulant dependence: a national drug abuse treatment clinical trials network study. Am J Addict (2009) 1.03

HIV testing and treatment with correctional populations: people, not prisoners. J Health Care Poor Underserved (2010) 1.00

Flavor improvement does not increase abuse liability of nicotine chewing gum. Pharmacol Biochem Behav (2002) 0.98

Using a latent variable approach to inform gender and racial/ethnic differences in cocaine dependence: a National Drug Abuse Treatment Clinical Trials Network study. J Subst Abuse Treat (2010) 0.97

Young incarcerated men's perceptions of and experiences with HIV testing. Am J Public Health (2007) 0.97

Voucher-based reinforcement of opiate abstinence during methadone detoxification. Drug Alcohol Depend (2002) 0.97

Effects of selegiline (L-deprenyl) during smoking and short-term abstinence. Psychopharmacology (Berl) (2002) 0.96

Identifying provider beliefs related to contingency management adoption using the contingency management beliefs questionnaire. Drug Alcohol Depend (2011) 0.93

Cash value of voucher reinforcers in pregnant drug-dependent women. Exp Clin Psychopharmacol (2005) 0.92

Prevalence and impact of alcohol and other drug use disorders on sedation and mechanical ventilation: a retrospective study. BMC Anesthesiol (2007) 0.91

Buprenorphine medication versus voucher contingencies in promoting abstinence from opioids and cocaine. Exp Clin Psychopharmacol (2009) 0.91

Characterizing smoking, cessation services, and quit interest across outpatient substance abuse treatment modalities. J Subst Abuse Treat (2013) 0.90

Infrequent illicit methadone use among stimulant-using patients in methadone maintenance treatment programs: a national drug abuse treatment clinical trials network study. Am J Addict (2008) 0.89

Contingency management in cocaine abusers: a dose-effect comparison of goods-based versus cash-based incentives. Exp Clin Psychopharmacol (2007) 0.88

Is exposure to an effective contingency management intervention associated with more positive provider beliefs? J Subst Abuse Treat (2011) 0.88

Impact of self-initiated pre-quit smoking reduction on cessation rates: results of a clinical trial of smoking cessation among female prisoners. Addict Behav (2010) 0.86

Voucher reinforcement for heroin and cocaine abstinence in an outpatient drug-free program. Exp Clin Psychopharmacol (2002) 0.86

Predictors of involvement in the juvenile justice system among psychiatric hospitalized adolescents. Addict Behav (2008) 0.86

The brief abstinence test: effects of continued incentive availability on cocaine abstinence. Exp Clin Psychopharmacol (2002) 0.85

Characterizing smoking topography of cannabis in heavy users. Psychopharmacology (Berl) (2011) 0.85

Buprenorphine and medication management in a community corrections population: a pilot study. J Addict Med (2013) 0.85

Promoting careers in academic research to psychiatry residents. Acad Psychiatry (2014) 0.85

HIV rapid testing in drug treatment: comparison across treatment modalities. J Subst Abuse Treat (2012) 0.84

Results of a pilot randomized controlled trial of buprenorphine for opioid dependent women in the criminal justice system. Drug Alcohol Depend (2011) 0.84

Rewarding early abstinence in Veterans Health Administration addiction clinics. J Subst Abuse Treat (2013) 0.83

The impact of quitting smoking on weight among women prisoners participating in a smoking cessation intervention. Am J Public Health (2010) 0.83

A preliminary investigation of rapid smoking as a lapse-responsive treatment for tobacco dependence. Exp Clin Psychopharmacol (2006) 0.81

Aftercare plans of inpatients undergoing detoxification. Am J Drug Alcohol Abuse (2007) 0.81

Brief motivational interventions for HIV/STI risk reduction among individuals receiving alcohol detoxification. AIDS Educ Prev (2009) 0.81

A randomized study of contingency management and spirometric lung age for motivating smoking cessation among injection drug users. BMC Public Health (2014) 0.80

A comparison of voucher-delivery schedules for the initiation of cocaine abstinence. Exp Clin Psychopharmacol (2005) 0.80

Pay-for-performance in a community substance abuse clinic. J Subst Abuse Treat (2011) 0.79

Ten take home lessons from the first 10 years of the CTN and 10 recommendations for the future. Am J Drug Alcohol Abuse (2011) 0.79

Single- versus dual-drug target: effects in a brief abstinence incentive procedure. Exp Clin Psychopharmacol (2003) 0.78

Predictors of condom use in women receiving court-mandated drug and alcohol treatment: implications for intervention. AIDS Care (2014) 0.78

HIV/AIDS research in correctional settings: perspectives on training needs from researchers and IRB members. AIDS Educ Prev (2014) 0.78

Depressive symptoms in adolescents during residential treatment for substance use disorders. Am J Addict (2004) 0.76

An implementation-focused process evaluation of an incentive intervention effectiveness trial in substance use disorders clinics at two Veterans Health Administration medical centers. Addict Sci Clin Pract (2014) 0.76

Balancing Beneficence and Autonomy. Am J Bioeth (2015) 0.75

Cocaine abstinence during methadone maintenance: effects of repeated brief exposure to voucher-based reinforcement. Exp Clin Psychopharmacol (2004) 0.75

Responsible opioid use. J Pain Palliat Care Pharmacother (2015) 0.75

Opioid Analgesics and Nicotine: More Than Blowing Smoke. J Pain Palliat Care Pharmacother (2015) 0.75

Factors related to injection drug use among female prisoners. Subst Use Misuse (2010) 0.75